Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion type Assertion NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_head.
- NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion description "[We investigated genetically affected leukemic cells in FIP1L1-PDGFRA+ chronic eosinophilic leukemia (CEL) and in BCR-ABL1+ chronic myeloid leukemia (CML), two myeloproliferative disorders responsive to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_provenance.
- NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion evidence source_evidence_literature NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_provenance.
- NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion SIO_000772 17215855 NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_provenance.
- NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion wasDerivedFrom befree-20150227 NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_provenance.
- NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_assertion wasGeneratedBy ECO_0000203 NP951634.RAvHiAJHDnO-eSi6qivdqsLU1U5Hm2qtoty4j9UjBruB4130_provenance.